UNSPSC 51283502: Dicloxacillin

This classification denotes a penicillin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier COF19H7WBK. European Medicines Agency schedules Dicloxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07099MIG. Dicloxacillin generally arises in the molecular formula C19H17CL2N3O5S.

UNSPSC 51283502 Dicloxacillin is a Commodity code that sits beneath pharmaceutical procurement activity, but recent state and local opportunities tagged to this code show minimal direct relevance to the nominal product. The source records four recent solicitations: Seminole County, Florida seeking naloxone and drug deactivation systems; Texas HHS Commission issuing a market-intelligence RFI on direct-to-manufacturer prescription programs; the City of Tampa procuring medical and first aid supplies for the fire rescue division; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) establishing contracts for generic multi-source pharmaceuticals and OTC products. Only the MMCAP opportunity addresses pharmaceuticals directly; the others address naloxone (an opioid antagonist, not an antibiotic), emergency medical supplies, and drug deactivation systems. None of the recent opportunities explicitly name dicloxacillin or penicillin-class antibiotics as line items. State and local procurement under this code appears to involve health departments, county government, fire services, and multi-state cooperative purchasing vehicles, but the tagged opportunities do not demonstrate active demand for this specific antibiotic.

The geographic spread of recent activity spans Florida (Seminole County), Texas (state HHS), Florida (Tampa), and Minnesota with multi-state reach (MMCAP, including Oregon participants). The MMCAP RFP, due March 26, 2026, represents the largest and most formal pharmaceutical procurement on record here, structured around NDC-specific generic pharmaceuticals supplied through three authorized wholesalers, with a two-year initial term and performance penalties for non-compliance. The City of Tampa's ITB for medical and first aid supplies, due March 13, 2026, is sheltered exclusively for certified Small Local Business Enterprises with a 5 percent bid discount (not to exceed $10,000) and an estimated contract value of $700,000. Seminole County's IFB, due July 26, 2023 (an inconsistency in the source record), seeks 1,900 units of naloxone annually with quarterly deliveries. The Texas HHS RFI, closed April 3, 2026, was exploratory market research rather than a competitive solicitation. The code shows modest and scattered state and local activity; dicloxacillin specifically does not appear to be actively procured under recent opportunities in this dataset.